3506
J. Chen et al. / Tetrahedron 66 (2010) 3499–3507
solvent was concentrated in vacuo. Flash chromatography of the
53% yield) as a white solid. Mp 142.0–143.0 ꢁC; IR (KBr): 3413, 3005,
2925, 1715, 1422, 1363, 1221, 1093, 902, 786 cmꢀ1; 1H NMR (CDCl3,
residue over silica gel (petroleum ether/EtOAc, 2:1) afforded amide
20
malyngamide M (1) (18 mg, 67% yield) as a pale yellow oil. [
a]
ꢀ31
400 MHz)
d
1.40 (s, 9H, 3ꢃCH3), 4.37 (d, J¼5.2 Hz, 2H, NCH2), 4.64
D
20
(c 0.1, MeOH) [Ref. 6 [
2855, 1629, 1463, 1209, 1095, 972, 746 cmꢀ1
400 MHz)
0.88 (t, 3H, J¼6.2 Hz, H-14),1.20–1.39 (m,10H, 5ꢃCH2, H-
a]
ꢀ35 (c 0.06, MeOH)]; IR (KBr): 3275, 2927,
(br, 1H, NH), 6.38 (s, 1H, H-3), 7.27–7.31 (m, 4H, 4ꢃArH); 13C NMR
D
;
1H NMR (Me2CO-d6,
(CDCl3, 100 MHz) d 28.3 (CH3), 39.5 (NCH2), 79.7 (C), 118.8 (CH, C-3),
d
128.0 (ArCH), 128.8 (ArCH), 134.2 (ArC), 135.7 (ArC), 139.4 (C-2),
155.6 (ArC); HRMS (ESI) m/z C14H21Cl2N2O2 [MþNH4]þ calcd for
319.0975, found 317.0983. The Z-configuration of Z-19 was con-
firmed by its NOE experiment. Selective irradiation of H-3 of 19
resulted in signal enhancement of H-60. However, there is no signal
enhancement of H-3 when irradiated H-1.
9, H-10, H-11, H-12, and H-13),1.40–1.45 (m, 2H, CH2, H-8), 2.12–2.20
(m, 2H, H-6), 2.21 (s, 3H, H-700), 2.28–2.33 (q, 2H, J¼7.4 Hz, H-3), 2.52
(t, 2H, J¼7.4 Hz, H-2), 3.12–3.16 (m,1H, H-7), 3.27 (s, 3H, OCH3, H-15),
3.29 (s, 3H, NCH3), 4.10 (s, 2H, H-10), 5.50–5.54 (m, 2H, H-4 and H-5),
6.39 (s,1H, H-30), 6.73 (t,1H, J¼7.4 Hz, H-500), 6.85 (d,1H, J¼7.4 Hz, H-
600), 7.07 (d, 1H, J¼7.4 Hz, H-400), 8.95 (br, 1H, ArOH); 13C NMR
According to the preceding procedure for the preparation of
malyngamide M (1), Z-19 (50 mg, 0.16 mmol) afforded E-19 (26 mg,
43% yield) as a white solid. Mp 62.0–63.0 ꢁC; IR (KBr): 3369, 2919,
(Me2CO-d6, 100 MHz) d
14.3 (CH3, C-14), 16.4 (CH3, C-700), 23.3 (CH2,
C-13), 25.9 (CH2, C-9), 28.6 (CH2, C-3), 29.9 (CH2, C-10), 30.1 (CH2, C-
11), 32.5 (CH2, C-12), 33.6 (CH2, C-2), 34.1 (CH2, C-8), 37.2 (CH2, C-6),
38.0 (NCH3), 53.8 (CH2, C-10), 56.5 (OCH3, C-15), 81.3 (CH, C-7),116.8
(CH, C-30), 119.6 (CH, C-500), 123.1 (C, C-100), 126.1 (C, C-300), 128.1 (CH,
C-5),128.2 (CH, C-600),131.5 (CH, C-400),131.9 (CH, C-4),138.6 (C, C-20),
153.5 (C, C-200), 174.2 (C, C-1); HRMS (ESI) m/z C26H41ClNO3 [MþH]þ
calcd for 450.2769, found 450.2763.
1716, 1366, 1217, 1168, 1026, 786 cmꢀ1 1H NMR (CDCl3, 400 MHz)
;
d
1.40 (s, 9H, 3ꢃCH3), 4.04 (d, J¼4.8 Hz, 2H, NCH2), 4.63 (br, 1H, NH),
6.33 (s, 1H, H-3), 7.26–7.28 (m, 2H, 2ꢃArH), 7.35–7.38 (m, 2H,
2ꢃArH); 13C NMR (CDCl3, 100 MHz)
d 28.3 (CH3), 45.5 (NCH2), 79.9
(C), 116.7 (CH, C-3), 128.6 (ArCH), 129.8 (ArCH), 133.9 (ArC), 134.0
(ArC), 138.7 (C-2), 155.4 (ArC); HRMS (ESI) m/z C14H21Cl2N2O2
[MþNH4]þ calcd for 319.0975, found 317.0983.
4.16. (Z)/(E)-N-(tert-Butoxycarbonyl)-3-chloro-2-phenyl-
prop-2-en-amine (Z-18 and E-18)
Acknowledgements
The authors are grateful to the National Basic Research Program
of China (973 Program) (Grant No. 2010CB833203), the National
Natural Science Foundation of China (Grant Nos. 20872055 and
20972060), Specialized Research Fund for the Doctoral Program of
Higher Education, and the 111 Project for continuing financial
support. We also gratefully acknowledge Professor Hak-Fun Chow,
The Chinese University of Hong Kong, for his helpful guidance in
revising the manuscript.
As above described procedure for the preparation of 9, 2-N-(tert-
butoxycarbonyl)amino-1-phenylethanone21 (235 mg, 1.00 mmol)
afforded vinyl chloride Z-18 (Z-18/E-18¼1:1) (116 mg, 43% yield) as
a white solid. Mp 157–158 ꢁC; IR (KBr): 3422, 3005, 2970, 1715,
References and notes
1421, 1363, 1221, 1092, 902, 786 cmꢀ1 1H NMR (CDCl3, 400 MHz)
;
d
1.39 (s, 9H, 3ꢃCH3), 4.40 (d, J¼5.6 Hz, 2H, NCH2), 4.64 (br, 1H, NH),
1. (a) Cardellina, J. H., II; Dalietos, D.; Marner, F. J.; Mynderse, J. S.; Moore, R. E.
Phytochemistry 1978, 17, 2091; (b) Li, Y.; Feng, J. P.; Wang, W. H.; Chen, J.; Cao, X.
P. J. Org. Chem. 2007, 72, 2344 and reference therein.
2. Suntornchashwej, S.; Suwanborirux, K.; Isobe, M. Tetrahedron 2007, 63, 3217.
3. Feng, J. P.; Shi, Z. F.; Li, Y.; Zhang, J. T.; Qi, X. L.; Chen, J.; Cao, X. P. J. Org. Chem.
2008, 73, 6873.
4. Chen, J.; Li, Y.; Cao, X. P. Tetrahedron: Asymmetry 2006, 17, 933.
5. Chen, J.; Fu, X. G.; Zhou, L.; Zhang, J. T.; Qi, X. L.; Cao, X. P. J. Org. Chem. 2009, 74,
4149 and reference therein.
6. Kan, Y.; Fujita, T.; Nagai, H.; Sakamoto, B.; Hokama, Y. J. Nat. Prod. 1998, 61, 152.
7. Li, Y.; Chen, J.; Cao, X. P. Synth. 2006, 320.
8. Toyoda, T.; Sasakura, K.; Sugasawa, T. J. Org. Chem. 1981, 46, 189.
9. (a) Peese, K. M.; Gin, D. Y. J. Am. Chem. Soc. 2006, 128, 8734; (b) Ursini, C. V.;
Mazzeo, F.; Rodrigues, J. A. R. Tetrahedron: Asymmetry 2006, 17, 3335; (c) Peach,
P.; Cross, D. J.; Kenny, J. A.; Mann, I.; Houson, I.; Campbell, L.; Walsgrove, T.;
Wills, M. Tetrahedron 2006, 62, 1864.
10. (a) Chrovian, C. C.; Knapp-Reed, B.; Montgomery, J. Org. Lett. 2008, 10, 811; (b)
Jin, Y. L.; Kim, S.; Kim, Y. S.; Kim, S. A.; Kim, H. S. Tetrahedron Lett. 2008, 49,
6835.
11. (a) Chowdari, N. S.; Ahmad, M.; Albertshofer, K.; Tanaka, F.; Barbas, C. F., III.
Org. Lett. 2006, 8, 2839; (b) Vallinayagam, R.; Schmitt, F.; Barge, J.; Wagnieres,
G.; Wenger, V.; Neier, R.; Juillerat-Jeanneret, L. Bioconjugate Chem. 2008, 19,
821.
12. (a) Kahnberg, P.; Lee, C. W.; Grubbs, R. H.; Sterner, O. Tetrahedron 2002,
58, 5203; (b) Kahnberg, P.; Sterner, O. Tetrahedron 2001, 57, 7181; (c) Gruijters, B.
W. T.;Veldhuizen, A. V.; Weijers, C. A. G. M.; Wijnberg, J. B. P. A. J. Nat. Prod. 2002, 65,
558.
6.38 (s, 1H, H-3), 7.26–7.36 (m, 5H, 5ꢃArH); 13C NMR (CDCl3,
100 MHz)
d 28.3 (CH3), 39.6 (NCH2), 79.5 (C), 118.3 (CH, C-3), 126.5
(ArCH), 128.2 (ArCH), 128.6 (ArCH), 137.2 (C, C-2), 140.1 (ArC), 155.6
(ArC); HRMS (ESI) m/z C14H18ClNO2Na [MþNa]þ calcd for 290.0918,
found 290.0921. The Z-configuration of Z-18 was confirmed by its
NOE experiment. Selective irradiation of H-3 of 18 resulted in signal
enhancement of H-60. However, there is no signal enhancement of
H-3 when irradiated H-1.
According to the preceding procedure for the preparation of
malyngamide M (1), Z-18 (20 mg, 0.07 mmol) afforded E-18 (9 mg,
45%yield)asawhitesolid. Mp74.0–75.0 ꢁC;IR(KBr):3390,2979,1702,
1490, 1367, 1250, 1166, 1092, 838 cmꢀ1 1H NMR (CDCl3, 400 MHz)
;
d
1.42 (s, 9H, 3ꢃCH3), 4.08 (d, J¼5.2 Hz, 2H, NCH2), 4.61 (br, 1H, NH),
6.34 (s,1H, H-3), 7.27–7.43 (m, 5H, 5ꢃArH); 13C NMR (CDCl3,100 MHz)
d
28.3 (CH3), 45.7 (NCH2), 79.7 (C),116.2 (CH, C-3),128.1 (ArCH), 128.3
(ArCH), 128.4 (ArCH), 135.6 (C, C-2), 139.7 (ArC), 155.5 (ArC); HRMS
(ESI) m/zC14H18ClNO2Na [MþNa]þ calcdfor290.0918,found290.0921.
4.17. (Z)/(E)-N-(tert-Butoxycarbonyl)-3-chloro-2-(4-
chlorophenyl)-prop-2-en-amine (Z-19 and E-19)
13. Arda´, A.;Soengas,R.G.;Nieto,M.I.;Jime´nez,C.;Rodrı´guez,J.Org. Lett.2008,10,2175.
14. Hanawa, H.; Hashimoto, T.; Maruoka, K. J. Am. Chem. Soc. 2003, 125, 1708.
15. (a) Paterson, I.; Razzak, M.; Anderson, E. A. Org. Lett. 2008, 10, 3295; (b) Corey,
E. J.; Fuch, P. L. Tetrahedron Lett. 1972, 13, 3769.
16. (a) Dryden, H. L., Jr.; Webber, G. M.; Burtner, R. R.; Cella, J. A. J. Org. Chem. 1961,
26, 3237; (b) Guo, Z.; Schultz, A. G. J. Org. Chem. 2001, 66, 2154.
17. Xu, L. B.; Jin, J.; Lal, M.; Daublain, P.; Newcomb, M. Org. Lett. 2007, 9, 1837.
18. (a) Todd, J. S.; Gerwick, W. H. Tetrahedron Lett. 1995, 36, 7837; (b) Wu, M.;
Milligan, K. E.; Gerwick, W. H. Tetrahedron 1997, 53, 15983; (c) Gallimore, W.
A.; Scheuer, P. J. J. Nat. Prod. 2000, 63, 1422; (d) Milligan, K. E.; Ma´rquez, B.;
Williamson, R. T.; Davies-Coleman, M.; Gerwick, W. H. J. Nat. Prod. 2000, 63,
965; (e) Kan, Y.; Sakamoto, B.; Fujita, T.; Nagai, H. J. Nat. Prod. 2000, 63,
1599.
As above described procedure for the preparation of 9, 2-N-(tert-
butoxycarbonyl)amino-1-(4-chlorophenyl) ethanone22 (270 mg,
1.00 mmol) afforded vinyl chloride Z-19 (Z-19/E-19¼1:1) (160 mg,